The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

Thu, 27th Feb 2020 17:56

(Alliance News) - The following is a round-up of company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Burford Capital Ltd - The litigation finance firm adds Christopher Bogart, chief executive officer and a company founder, to the board, as proposed back in January. Also hires Robert Gillespie, most recently director general of the UK Takeover Panel, and John Sievwright, former chief operating officer for International at Merrill Lynch, as independent non-executive directors. Peter Middleton to step down as chair at 2021 annual general meeting, succeeded by Deputy Chair Steve Wilson. Burford said it will continue to refresh its board and expects to add a further independent director prior to the 2021 AGM. The company is seeking a US listing, and it said Thursday that if successful, it will look to add another US director. Burford was the target of a short-selling attack back in August of last year by Muddy Waters Capital LLC, which charged that Burford "is a poor business masquerading as a great one".

----------

OnTheMarket PLC - Property portal hires Rupert Sebag-Montefiore as independent non-executive director. Sebag-Montefiore served as chief executive officer of estate agent Savills PLC's principal UK subsidiary, as well as head of Global Residential.

----------

Laura Ashley Holdings PLC - Chief Executive Officer Kwan Cheong Ng steps down Thursday to become non-executive director. Had been expected to remain an executive director until end of April. Chief Operating Officer Katharine Poulter promoted to CEO.

----------

ConvaTec Group PLC - Hires Brian May as non-executive director from March 2. May was chief financial officer of Bunzl PLC from 2016 to 2019.

----------

RSA Insurance Group PLC - Alastair Barbour plans to step down as non-executive director in early October, having served nine years on the insurer's board. Clare Bousfield joins board on April 1 and will succeed Barbour as chair of audit committee in October.

----------

AFC Energy PLC - Company Secretary Graeme Lewis to become finance director as well.

----------

REACT Group PLC - Appoints Shaun Doak, managing director of REACT Specialist Cleaning Ltd, to board. Gill Leates moves from executive to non-executive chair. Both changes immediate.

----------

Open Orphan PLC - Chief Financial Officer Leo Toole added to board. Toole was interim CFO and then confirm as permanent earlier this month. He is a 20-year pharmaceuticals and medical technology veteran, having held senior finance positions at the US's Procter & Gamble Co and other multinationals.

----------

Frenkel Topping Group PLC - Elaine Cullen-Grant promoted from financial controller to the board as chief financial officer. Cullen-Grant succeeds Stephen Bentley, who retires on March 1.

----------

Dialight PLC - Karen Oliver and Gotthard Haug hired as non-executive directors from April 1. Oliver is former managing director of Johnson Matthey PLC's Chemicals business. Haug is executive chair of electronics repair and service provider Ivy Technology. Steve Good to step down as director from March 31.

----------

Baronsmead Second Venture Trust PLC - Tim Farazmand hired as independent non-executive director from May 1. Was chair of the British Venture Capital Association.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2022 11:45

Open Orphan's hVIVO wins GBP14.7 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said it's subsidiary hVIVO signed a GBP14.7 million contract for an influenza characterisation study and a follow on influenza human challenge study.

Read more
31 May 2022 16:05

UK earnings, trading statements calendar - next 7 days

Wednesday 1 June  
Impax Asset Management Group PLCHalf Year Results
Dr Martens PLCFull Year Results
Thursday 2 June  
no events scheduled 
Friday  3 June  
no events scheduled  
Monday 6 June  
Atrato Onsite Energy PLCHalf Year Results
Empiric Student Property PLCTrading Statement
Jadestone Energy PLCFull Year Results
Tuesday 7 June  
Gooch & Housego PLCHalf Year Results
LXi REIT PLCFull Year Results
NewRiver REIT PLCFull Year Results
Open Orphan PLCFull Year Results
Schroder Real Estate Investment Trust LtdFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 May 2022 16:43

Open Orphan's hVIVO wins GBP7.3 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said its subsidiary hVIVO Ltd has signed a GBP7.3 million contract.

Read more
18 May 2022 15:15

Open Orphan wins £7.3m human flu study contract

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Wednesday that its hVIVO subsidiary has signed a £7.3m flu human challenge study contract with an unnamed biotechnology company, to test its antiviral product using hVIVO's influenza human challenge study model.

Read more
6 May 2022 19:11

TRADING UPDATES: Enwell pleased with SV-31; SDX Energy ties in well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 May 2022 14:53

IN BRIEF: Open Oprhan wins contract for vaccine field site study

Open Orphan PLC - London-based pharmaceutical services - Subsidiary hVIVO is awarded new study with existing unnamed pharmacetical client to act as vaccination site for the client's respiratory syncytial virus vaccine candidate. hVIVO's specialist arm FluCamp will recruit 60 healthy volunteers to the new site clinic at Plumbers Row where trials will take place.

Read more
13 Apr 2022 19:46

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
1 Apr 2022 20:23

IN BRIEF: Open Orphan Covid study results published in Nature Medicine

Open Orphan PLC - London-based pharmaceutical services - Says Thursday that results from the world's first Covid-19 characterisation study have been peer reviewed and published in the scientific journal Nature Medicine. Says study showed the SARS-CoV-2 human challenge was safe in healthy young adults and provided insights into the course of Covid-19 infection with potential positive public health implications. With the characterisation study disease modelling data completed, and human challenge model established, Open Orphan says it should be able to conduct Covid-19 human challenge studies in 2022.

Read more
25 Mar 2022 14:10

IN BRIEF: Open Orphan wins GBP5 million human challenge study pact

Open Orphan PLC - London-based pharmaceutical services firm - Says its subsidiary, hVIVO, wins contract with a European biotechnology company for a human challenge study. The GBP5 million contract with a European biotech seeks to test hVIVO's intravenous antiviral candidate. The study on the respiratory syncytial virus is expected to commence this year. Revenue from the deal will be recognised across 2022 and 2023.

Read more
25 Mar 2022 09:39

Open Orphan wins £5m contract for human study in RSV

(Sharecast News) - Open Orphan announced on Friday that its hVIVO subsidiary has signed a £5m respiratory syncytial virus (RSV) human challenge study contract with an unnamed European biotechnology company, to test its intravenous antiviral candidate.

Read more
8 Mar 2022 19:37

IN BRIEF: Open Orphan expects to report profitable 2021 performance

Open Orphan PLC - London-based pharmaceutical services - For 2021, expects to report earnings before interest, tax, depreciation and amortisation, on revenue which is set to be GBP40 million, up from GBP20.6 million in 2020. For 2022, the company is targeting GBP50 million in non-Covid work revenue.

Read more
24 Feb 2022 15:24

Open Orphan appoints Mo Khan as its new chief executive

(Sharecast News) - Contract research organisation Open Orphan announced the appointment of Yamin 'Mo' Khan as its chief executive officer on Thursday, with immediate effect.

Read more
24 Feb 2022 14:48

IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive

Open Orphan PLC - London-based pharmaceutical services - Moves Non-Executive Director Mo Khan to chief executive officer, effective immediately. Khan had joined the Open Orphan board back in October. The company notes he has 25 years of clinical research experience. Cathal Friel remains executive chair, while Open Orphan will aim to find a new independent non-executive director within the next six months.

Read more
22 Feb 2022 21:57

TRADING UPDATES: Angling Direct ups revenue; Ceiba takes Omicron hit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
17 Feb 2022 20:13

IN BRIEF: Positive results from Open Orphan human challenge study

Open Orphan PLC - pharmaceutical services provider - Sees positive results from a human challenge study assessing its respiratory syncytial virus antiviral candidate, EDP-938. Says results from the study have been published in The New England Journal of Medicine. hVIVO, a subsidiary of Open Orphan, conducted the Phase 2a, double-blind, placebo-controlled trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.